Medical Director, US Medical Affairs, HCM at Cytokinetics in SSF

Job description

Cytokinetics is a specialty cardiovascular biopharmaceutical company, building on its over 25 years of pioneering scientific innovations in muscle biology, and advancing a pipeline of potential new medicines for patients suffering from diseases of cardiac muscle dysfunction. The Medical Director, US Medical Affairs, Hypertrophic Cardiomyopathy will assume a key role within the organization. S/he will work collaboratively with other members of the Medical Affairs team in the development and execution of the Medical Affairs plan for aficamten and partner cross-functionally with the Commercial and Clinical departments in the strategic planning and life-cycle management process of our CV portfolio. As a subject matter expert in cardiology and hypertrophic cardiomyopathy, the Medical Director will provide support to internal colleagues, resolve medical issues, and provide critical input into the development of medical documents (publications, external scientific communications, standard response letters, training materials, product materials, research ideas, internal training materials, etc.) to ensure high strategic and scientific standards. Importantly, the Medical Director will serve as a key member of the Medical Affairs Hypertrophic Cardiomyopathy team. S/he may represent Medical Affairs externally through presentations at advisory boards, key scientific meetings, and interactions with our key investigators. Additionally, the Medical Director will support strategic partnerships with key opinion leaders, academic institutions, and professional societies. Responsibilities: Supports the ongoing development of aficamten , including Assist in development and execution of medical strategy, including the US Plan of Action, aligned with organizational, therapeutic area, and product objectives Serve as a medical and scientific expert for the assigned therapeutic area Educate HCPs regarding the clinical profile of aficamten and its place in HCM therapy Provide medical leadership throughout aficamten development, launch readiness, and lifecycle management Execution of medical launch activities Provide medical input into cross-functional, brand, evidence generation, market access, and lifecycle management plans Provide medical expertise and input for REMS activities Partner with Clinical Development, Commercial, Regulatory, Safety, HEOR, Market Access, and Legal/Compliance on key strategic workstreams and deliverables. Projects may include scientific congress strategy and planning, advisory boards, field force training, review of medical information standard response letters, health economics and epidemiology analyses, and marketing and policy related projects Collaborate with regional and global colleagues to ensure aligned strategy while effectively addressing local stakeholder needs Participate in appropriate cross‐functional Medical and Commercial teams to inform brand strategies and tactics for aficamten Provide input into hypertrophic cardiomyopathy medical education, grant, and sponsorship review and review metrics to evaluate the reach, quality, and impact of medical education initiatives. Manage medical programs, vendors, timelines, budgets, contracts, and performance measures. Provide clinical and scientific support in responding to inquiries from healthcare professionals Support the Medical Affairs review of medical and promotional scientific materials related to hypertrophic cardiomyopathy and aficamten via MLR Participate in development of integrated evidence plan strategy (IEP), including identification of evidence gaps and contribute to evidence generation strategy including real-world evidence and investigator-sponsored research Collaborate with Field Medical Affairs to establish scientific priorities, training plans, and insight and stakeholder engagement strategy. Analyze field medical insights to inform medical, evidence generation, and educational strategy Collaborate with US Field Medical Affairs to support field mate